Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Beard Bros Pharms has shown varied performance across different states and categories, with notable movements in the concentrates category. In California, the brand did not make it into the top 30 rankings from October 2024 to January 2025, indicating potential challenges in this competitive market. Despite this, the brand has maintained a presence, suggesting ongoing efforts to capture market share. In contrast, in Massachusetts, Beard Bros Pharms reached the 52nd position in November 2024, although it didn't sustain this ranking in subsequent months. This suggests a brief period of increased visibility or a targeted campaign that temporarily boosted its presence in the state.
The data reveals that while Beard Bros Pharms has struggled to break into the top 30 in some key markets, there are signs of potential growth and market penetration efforts. For instance, the brand's sales in Massachusetts during November 2024 indicate a strategic push or positive consumer reception during that period. However, the absence from the top rankings in both California and Massachusetts in other months suggests that the brand may need to adjust its strategies to achieve more consistent performance and visibility. This analysis highlights the dynamic nature of cannabis markets and the importance of sustained marketing and product differentiation efforts for brands like Beard Bros Pharms.
Competitive Landscape
In the competitive landscape of the California concentrates market, Beard Bros Pharms experienced a notable absence from the top 20 rankings from October 2024 to January 2025, indicating a potential challenge in maintaining visibility and market share. Meanwhile, competitors such as Beezle Extracts and Lowell Herb Co / Lowell Smokes maintained stronger positions, with Beezle Extracts securing the 87th rank in November 2024, and Lowell Herb Co / Lowell Smokes holding the 62nd rank in October 2024. Shaman Extracts showed a fluctuating performance, dropping from 48th in October 2024 to 99th by January 2025, which could suggest volatility in consumer preferences or distribution challenges. Traditional Co. demonstrated more stability, consistently ranking between 65th and 80th over the same period. These dynamics suggest that Beard Bros Pharms may need to reassess its strategies to enhance its competitive edge and regain a foothold in the California concentrates market.
Notable Products
In January 2025, the top-performing product for Beard Bros Pharms was the High THC Full Spectrum Oil Syringe (1g) in the Concentrates category, maintaining its first-place ranking from the previous two months with sales of 287 units. The CBD/THC 10:1 High Full Spectrum Oil (1g) also in Concentrates, held its position at second, consistent with its ranking in December 2024. The THC:CBD 20:1 HighTHC Spectrum Tincture (600mg THC, 30mg CBD, 30ml, 1oz) climbed to third place from fourth in December, showing a steady increase in demand. Meanwhile, the THC/CBN 2:1 Nighttime Tincture (600mg THC, 300mg CBN, 1oz) remained at fourth, indicating stable sales performance. Notably, the CBD Full Spectrum RSO Syringe (1g) in Concentrates slipped to fifth place, down from third in December 2024, suggesting a decline in its popularity.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.